Search

Author/Creator Fabbro, Michel

21. TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study. (20th April 2021)

Authors:
Tabouret, Emeline; Fabbro, Michel; Autran, Didier; Hoang-Xuan, Khe; Taillandier, Luc; Ducray, François; Barrie, Maryline; Sanson, Marc; Kerr, Christine; Cartalat-Carel, Stephanie; Loundou, Anderson; Guillevin, Remy; Mokhtari, Karima; Figarella-Branger, Dominique; Delattre, Jean-Yves; Chinot, Olivier
Journal:
Oncologist
Issue:
Volume 26:Number 8(2021)
Page Start:
647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study. (20th April 2021)

Authors:
Tabouret, Emeline; Fabbro, Michel; Autran, Didier; Hoang‐Xuan, Khe; Taillandier, Luc; Ducray, François; Barrie, Maryline; Sanson, Marc; Kerr, Christine; Cartalat‐Carel, Stephanie; Loundou, Anderson; Guillevin, Remy; Mokhtari, Karima; Figarella‐Branger, Dominique; Delattre, Jean‐Yves; Chinot, Olivier
Journal:
Oncologist
Issue:
Volume 26:Number 8(2021)
Page Start:
647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG). (22nd February 2018)

Authors:
Reyes‐Botero, Germán; Cartalat‐Carel, Stéphanie; Chinot, Olivier L.; Barrie, Maryline; Taillandier, Luc; Beauchesne, Patrick; Catry‐Thomas, Isabelle; Barrière, Jérôme; Guillamo, Jean‐Sebastien; Fabbro, Michel; Frappaz, Didier; Benouaich‐Amiel, Alexandra; Le Rhun, Emilie; Campello, Chantal; Tennev...
Journal:
Oncologist
Issue:
Volume 23:Number 5(2018)
Page Start:
524
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗